Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Journal of Clinical Immunology|June 29, 2021
Normal IgH Repertoire Diversity in an Infant with ADA Deficiency After Gene TherapyCarolyn H Baloh, Samiksha A Borkar, Kai-Fen Chang, et al.JAMA Dermatology|May 12, 2021
A Mutational Survey of Acral NeviKeiran S M Smalley, Jamie K Teer, Y Ann Chen, et al.British Journal of Cancer|October 7, 2020
Artificial selection for host resistance to tumour growth and subsequent cancer cell adaptations: an evolutionary arms raceArig Ibrahim-Hashim, Kimberly Luddy, Dominique Abrahams, et al.Scientific Reports|July 6, 2019
The Homeobox gene, HOXB13, Regulates a Mitotic Protein-Kinase Interaction Network in Metastatic Prostate CancersJiqiang Yao, Yunyun Chen, Duy T Nguyen, et al.Pharmacogenomics|January 8, 2024
Association between <i>CYP3A4</i>, <i>CYP3A5</i> and <i>ABCB1</i> genotype and tacrolimus treatment outcomes among allogeneic HSCT patientsTeresa T Ho, Janelle B Perkins, Rebecca Gonzalez, et al.Cell Metabolism|August 10, 2020
Sirt2 Inhibition Enhances Metabolic Fitness and Effector Functions of Tumor-Reactive T CellsImene Hamaidi, Lin Zhang, Nayoung Kim, et al.Cell Reports|March 5, 2026
Potentiating dendritic cell immunotherapy by interrupting the Semaphorin 4D-induced immune-suppressive barrierSaurabh K Garg, Colin Snyder, Ganesan Ramamoorthi, et al.Journal for Immunotherapy of Cancer|November 13, 2024
Differences in the pathological, transcriptomic, and prognostic implications of lymphoid structures between primary and metastatic cutaneous melanomasLilit Karapetyan, Aofei Li, Danielle Vargas De Stefano, et al.Nature Communications|May 25, 2026
Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trialJeffrey S Johnson, Justin W Miller, Firas Hatoum, et al.Molecular Cancer Therapeutics|September 23, 2018
Targeting the BRD4-HOXB13 Coregulated Transcriptional Networks with Bromodomain-Kinase Inhibitors to Suppress Metastatic Castration-Resistant Prostate CancerNiveditha Nerlakanti, Jiqiang Yao, Duy T Nguyen, et al.Pageof 4